PMID- 37735431 OWN - NLM STAT- MEDLINE DCOM- 20230927 LR - 20231120 IS - 1749-799X (Electronic) IS - 1749-799X (Linking) VI - 18 IP - 1 DP - 2023 Sep 21 TI - DAP1 regulates osteoblast autophagy via the ATG16L1-LC3 axis in Graves' disease-induced osteoporosis. PG - 711 LID - 10.1186/s13018-023-04171-z [doi] LID - 711 AB - OBJECTIVE: This study aimed to uncover a critical protein and its mechanisms in modulating autophagy in Graves' disease (GD)-induced osteoporosis (OP). METHODS: We discovered the target protein, death-associated protein 1 (DAP1), using bone proteomics analysis. Furthermore, genetic overexpression and knockdown (KD) of DAP1 in bone and MC3T3-E1 cells revealed DAP1 effects on autophagy and osteogenic markers, and autophagic vacuoles in cells were detected using transmission electron microscopy and the microtubule-associated protein 1 light chain 3 alpha (MAP1LC3/LC3) dual fluorescence system. An autophagy polymerase chain reaction (PCR) array kit was used to identify the key molecules associated with DAP1-regulated autophagy. RESULTS: DAP1 levels were significantly higher in the bone tissue of GD mice and MC3T3-E1 cells treated with triiodothyronine (T3). DAP1 overexpression reduced LC3 lipidation, autophagic vacuoles, RUNX family transcription factor 2 (RUNX2), and osteocalcin (OCN) expression in MC3T3-E1 cells, whereas DAP1 KD reversed these changes. In vivo experiments revealed that GD mice with DAP1 KD had greater bone mass than control mice. DAP1-overexpressing (OE) cells had lower levels of phosphorylated autophagy-related 16-like 1 (ATG16L1) and LC3 lipidation, whereas DAP1-KD cells had higher levels. CONCLUSIONS: DAP1 was found to be a critical regulator of autophagy homeostasis in GD mouse bone tissue and T3-treated osteoblasts because it negatively regulated autophagy and osteogenesis in osteoblasts via the ATG16L1-LC3 axis. CI - (c) 2023. BioMed Central Ltd., part of Springer Nature. FAU - Gao, Mingdong AU - Gao M AD - The First School of Clinical Medical, Lanzhou University, Lanzhou, 730030, Gansu, China. AD - Department Pediatrics, Gansu Provincial Hospital, Lanzhou, 730030, Gansu, China. AD - Clinical Research Center for Metabolic Diseases, Lanzhou, 730030, Gansu, China. FAU - Du, Zouxi AU - Du Z AD - The First School of Clinical Medical, Lanzhou University, Lanzhou, 730030, Gansu, China. FAU - Dong, Qianqian AU - Dong Q AD - The First School of Clinical Medical, Lanzhou University, Lanzhou, 730030, Gansu, China. FAU - Su, Shan AU - Su S AD - The First School of Clinical Medical, Lanzhou University, Lanzhou, 730030, Gansu, China. FAU - Tian, Limin AU - Tian L AD - The First School of Clinical Medical, Lanzhou University, Lanzhou, 730030, Gansu, China. tlm6666@sina.com. AD - Clinical Research Center for Metabolic Diseases, Lanzhou, 730030, Gansu, China. tlm6666@sina.com. AD - Department of Endocrinology, Gansu Provincial Hospital, No. 204 West Donggang Road, Lanzhou, 730030, Gansu, China. tlm6666@sina.com. LA - eng GR - 82060152/National Social Science Fund of China/ GR - 21JR11RA192/Natural Science Foundation of Gansu Province/ GR - 2018-RC-79/Lanzhou City Talent Innovation and Entrepreneurship Project/ PT - Journal Article DEP - 20230921 PL - England TA - J Orthop Surg Res JT - Journal of orthopaedic surgery and research JID - 101265112 RN - 0 (Atg16l1 protein, mouse) RN - 0 (Map1lc3b protein, mouse) SB - IM MH - Animals MH - Mice MH - Autophagy/genetics MH - Bone and Bones MH - *Graves Disease MH - Osteoblasts MH - *Osteoporosis/etiology PMC - PMC10512661 OTO - NOTNLM OT - Autophagy OT - Death-associated protein 1 OT - Graves' disease OT - Osteoblasts OT - Osteoporosis COIS- The authors declare that they have no competing interests. EDAT- 2023/09/22 06:42 MHDA- 2023/09/25 06:42 PMCR- 2023/09/21 CRDT- 2023/09/22 00:46 PHST- 2023/07/04 00:00 [received] PHST- 2023/09/07 00:00 [accepted] PHST- 2023/09/25 06:42 [medline] PHST- 2023/09/22 06:42 [pubmed] PHST- 2023/09/22 00:46 [entrez] PHST- 2023/09/21 00:00 [pmc-release] AID - 10.1186/s13018-023-04171-z [pii] AID - 4171 [pii] AID - 10.1186/s13018-023-04171-z [doi] PST - epublish SO - J Orthop Surg Res. 2023 Sep 21;18(1):711. doi: 10.1186/s13018-023-04171-z.